<DOC>
	<DOCNO>NCT01874730</DOCNO>
	<brief_summary>This multi-centre study take place approximately 3 center Seoul , South Korea . The study carry prospective , randomize , control , multicenter , clinical trial patient undergoing colorectal surgery . The purpose study determine enhance recovery strategy pay close attention type amount fluid give surgery proper monitoring combine comprehensive perioperative pain management well post-operative outcome compare institutional standard care ( SOC ) , patient undergo surgery colon . One fluid use , Volulyte® , intravenous solution use treat low blood volume . The Volulyte® solution use study monitor use approved Korean Food Drug Administration</brief_summary>
	<brief_title>KOREAN Enhanced RecOvery Strategy Colorectal Surgery</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Hydroxyethyl Starch Derivatives</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<criteria>1 . Elective , open colorectal surgery include sigmoid resection , i.e . upper rectal anastomosis without plan stoma . If plan surgery combine procedure , associated procedure add 1 hour surgery time primary colorectal surgical procedure alone . 2 . Both gender ; age ≥ 45 year ≤ 80 year . 3 . ASA Grades IIII 4 . Voluntary participation signing informed consent form 1 . Fluid overload ( hyperhydration ) , especially case pulmonary edema congestive heart failure , patient severe cardiovascular disorder ( New York Heart Association , NYHA IIIIV ) 2 . Patients significant cardiac arrhythmia depend pacemaker 3 . Patients impaired liver and/or kidney function ( ALT 2 time normal upper limit and/or Serum Creatinine ( SCr ) 2 time normal upper limit ) 4 . Renal failure oliguria anuria relate hypovolemia 5 . Patients receive dialysis treatment 6 . Patients nonresectable malignancy 7 . Patients noncooperative noncommunicable 8 . Patients significant preoperative coagulation abnormality 9 . Patients receive treatment opioids significant chronic pain 10 . Patients need organ transplantation 11 . Intracranial hemorrhage 12 . Severe hypernatremia ( Na+ &gt; 155 mmol/l ) severe hyperchloremia ( Cl &gt; 125 mmol/l ) 13 . Known hypersensitivity hydroxyethyl starch 14 . Participation clinical trial investigational drug device within 30 day study screen visit schedule receive investigational product participate study 15 . Patients evidence bowel obstruction symptom . 16 . Contraindication epidural anesthesia 17 . Known pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>colorectal surgery</keyword>
	<keyword>fluid therapy</keyword>
</DOC>